"10.1371_journal.pone.0078817","plos one","2013-11-12T00:00:00Z","Beda Brichacek; Laurel A Lagenaur; Peter P Lee; David Venzon; Dean H Hamer","Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America; Osel, Incorporated, Mountain View, California, United States of America; Biostatistics and Data Management Sect., National Cancer Institute, National Institutes of Health, Rockville, Maryland, United States of America","Performed the experiments: BB LAL. Analyzed the data: DV LAL BB. Contributed reagents/materials/analysis tools: DV. Wrote the paper: LAL BB. Conception and design of the work, acquisition of data, or analysis and interpretation of data: BB LAL. Analysis and interpretation of data: DV. Drafting the article or revising it critically for important intellectual content: DH PPL.","LAL, and PPL work for Osel Inc., a company developing genetically modified vaginal Lactobacillus. BB, DV and DHH have no conflict of interest. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","11","Beda Brichacek","BB",5,TRUE,NA,2,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
